BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250522T190000
DTEND;TZID=Africa/Nairobi:20250522T203000
DTSTAMP:20260522T082509
CREATED:20250520T103711Z
LAST-MODIFIED:20250622T142307Z
UID:24535-1747940400-1747945800@kesho-kenya.org
SUMMARY:Multidisciplinary Approaches to Paediatric Brain Tumours
DESCRIPTION:[vc_row][vc_column][vc_column_text]Moderator: Dr Alfred Odhiambo \nSpeakers & Topics: \n\nMr David L. Oluoch‑Olunya: Surgical Management of Paediatric Brain Tumours\nDr Michael Magoha: Endocrinological Management of Paediatric Brain Tumours\nDr Ahmed Korir: Radiation Therapy in Paediatric Brain Tumours\n\nMr. David Oluoch-Olunya presentation summary\n– Over 25 years\, Kenya has moved from fragmented care to growing multidisciplinary tumour boards in urban centres.\n– Key challenges remain: late diagnosis\, radiotherapy access disparities\, and poor survivorship follow-up.\n– Regional initiatives like the Brain Tumor Consortium of Africa (BTCoA) aim to standardize care and improve data sharing.\n– Priorities: expand MDT care to counties\, national paediatric tumour registry\, survivorship and rehab programs.\n– Kenya has made major strides\, but gaps persist in early detection\, diagnostics\, and referral systems. \nDr Ahmed Komen’s presentation summary \n– RT use depends on age\, tumour type/location\, other treatments\, and disease extent.\n– Modern RT techniques include 2D\, 3DCRT\, IMRT\, VMAT\, and proton therapy (where available).\n– RT aims: radical (curative) or palliative (symptom relief).\n– RT delivery to children requires precise planning and often sedation or anaesthesia.\n– Late effects of RT: cognitive decline\, growth delay\, hearing loss\, hormonal dysfunction\, secondary cancers.\n– Younger age (<7 yrs) and higher doses correlate with greater neurocognitive risks.\n– Proton therapy offers tissue-sparing benefits but has limited availability in LMICs.[/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/multidisciplinary-approaches-to-paediatric-brain-tumours/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/04/May-22nd-Poster-e1747737385167.jpg
END:VEVENT
END:VCALENDAR